SOURCE: Paragon Financial Limited

Paragon Financial Limited

April 23, 2012 08:20 ET

Drugs Store Industry Positioned to Benefit From Rapidly Aging Population

The Paragon Report Provides Stock Research on Walgreen Company and Rite Aid Corporation

NEW YORK, NY--(Marketwire - Apr 23, 2012) - Companies in the Drugs Store Industry have posted some impressive gains so far in 2012. As a result of an improving economy many have managed to increase sales, and grow through acquisitions. With the number of elderly in the U.S. rapidly increasing, potential growth for companies in the Drugs Store Industry continue to look strong. The Paragon Report examines investing opportunities in the Drug Stores Industry and provides equity research on Walgreen Company (NYSE: WAG) and Rite Aid Corporation (NYSE: RAD).

Access to full reports can be found at:

The aging U.S. population has continued to strengthen the demand for prescription drugs, as the elderly are more likely to suffer from medical ailments and historically spend more money on healthcare. January 2011 ushered in the first of approximately 77 million Baby Boomers into retirement, born from 1946 through 1964.Their swelling numbers predict that, by 2012, America's 50 and older population will reach 100 million. According to the federal Administration on Aging the nation's population of those 65 and older will double between 2000 and 2030.

Paragon Report releases regular market updates on the Drugs Store Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at and get exclusive access to our numerous stock reports and industry newsletters.

Walgreens recently reported March sales of $6.02 billion, a decrease of 4.3 percent from $6.29 billion for the same month in fiscal 2011. Total front-end sales increased 2.5 percent compared with the same month in 2011, while comparable store front-end sales increased 1.2 percent. Customer traffic in comparable stores decreased 1.0 percent while basket size increased 2.2 percent.

Rite Aid Corporation reported improved financial results for the fourth quarter and fiscal year ended March 3, 2012. For the fourth quarter, the company reported revenues of $7.1 billion, a net loss of $161.3 million or $0.18 per diluted share and Adjusted EBITDA of $274.3 million or 3.8 percent of revenues. Revenues improved by $690.3 million

Paragon Report provides Market Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. The Paragon Report has not been compensated by any of the above-mentioned companies. We act as independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at: